|Bid||2.50 x 500|
|Ask||4.50 x 500|
|Day's Range||22.00 - 24.00|
|52 Week Range||2.02 - 89.99|
|Beta (3Y Monthly)||10.10|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Phoenix Life Sciences International Limited (OTC:PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced it has completed the last stages the consolidation of businesses and received approval from the Financial Industry Regulatory Authority (“FINRA”) of the corporate action completing its name change and change of stock symbol. “After five years of planning and hard work, we could not be more excited to have completed this consolidation to build a world changing organization,” said Martin Tindall, CEO of Phoenix Life Sciences International. “This marks the end of what has been a long transitional period for our company and the beginning of a new chapter of opportunity for Phoenix Life.
Phoenix Life Sciences International Limited (MJMD) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that Col. Philip Blair, M.D. has become the Diabetes Director of the company’s Medical Advisory Council. U.S. Army veteran Dr. Philip Blair is a board-certified family physician who, since starting his company Pro Health Advisor in 2011, has provided innovative disease management by telemedicine to clients in all 50 states. A graduate from West Point and the University of Miami School of Medicine, he has been studying, treating and lecturing about the body’s natural endocannabinoid system (ECS) and the medicine behind cannabis since 2014.
Phoenix Life Sciences International Limited (MJMD) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that the company has received approval from the Vanuatu Investment Promotion Authority (VIPA) to establish operations in the country and manufacture botanical pharmaceutical products. The Republic of Vanuatu, an island chain in the South Pacific, is the target of the company’s first major production center. Phoenix Life is the first botanical researcher and producer to receive such approval in this nation.
Phoenix Life Sciences International Limited (MJMD) (“Phoenix Life”), an adaptive healthcare solutions company, today announced its new Board of Directors and executive team. “We have strategically selected these dedicated professionals based upon their ability to deliver and find creative solutions to help the company grow,” said Chief Executive Officer of Phoenix Life Martin Tindall. Phoenix Life aims to improve overall international health while reducing the cost of providing medical services and treatments.
Phoenix Life Sciences International Limited (“Phoenix Life”) (MJMD), an adaptive global healthcare solutions company, today announced that its Chief Executive Officer Martin Tindall will be speaking on an expert panel about pharmaceutical cannabis research at the Cannabis World Congress and Business Expo, taking place in Los Angeles on Thursday, Sept. 27, at 2 p.m. PT. “As cannabis research and innovation continues to flourish in the U.S. and throughout the world, I am proud to be at the forefront of this conversation and help people understand the many underutilized tools and resources that are available with plant-based medicines,” said Martin Tindall, incoming Chief Executive Officer of Phoenix Life Sciences International.
Phoenix Life Sciences International Limited (“Phoenix Life”) (MJMD), an adaptive global healthcare solutions company, today provided an update on the completion of merger documents with the Secretary of State in Nevada, as well as appointed a new renowned audit firm and retired a substantial amount of convertible debt. As a part of the final steps of its merger that created Phoenix Life Sciences International Limited, documents were processed through the Secretary of State for Nevada. The documents, including form and certificate of merger, were received back by the company, leaving only this week’s boards of directors’ appointments in the finalization of the company merger.